Swain SM, Miles D, Kim SB, Im YH, et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. Lancet Oncol 2020 Mar 12. pii: S1470-2045(19)30863.
PMID: 32171426